SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a ...

A new review was published in , Volume 16, on March 13, 2025, titled "Signaling pathway dysregulation in breast cancer." ...

A recent study suggests that using artificial intelligence to measure tumor size could reduce treatment failures by more than 70%.

Remains on Track to Initiate an Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma ...

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ...

AI-driven tumor mapping with Unfold AI helps doctors more accurately assess prostate cancer size, improving treatment success ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation in the tumor, ...